Using UNC's expertise to fight emerging diseases

Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (

Share: Facebook | Twitter | Email


Recent Campus Connections News:

How Carolina is transforming medicine with artificial intelligence

For 30 years, Stone Center has been bringing people together

Great college football (and foodie) towns to visit this fall

Hurricane Florence: How to support the recovery efforts

UNC-Chapel Hill to host shelter to serve people displaced by Hurricane Florence

© 2005-2018 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.